Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Illumina Names New Chief Executive
Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight with regulators. Source link
Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early
The European Union’s antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency
Farallon Capital to Wage Proxy Battle at Biotech Firm
WSJ News Exclusive Finance Farallon has nominated three directors to the board of Exelixis Source link
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
The agency said the combination would hurt competition for cancer-detection tests while raising prices. Source link
Stephens & Co. Initiates Coverage of 10x Genomics, Inc. (TXG) with Overweight Recommendation
On March 31, 2023, Stephens & Co. initiated coverage of 10x Genomics, Inc. with a Overweight recommendation. Analyst Price Forecast Suggests 5.48% Downside As of
Carl Icahn Wants to Bring Illumina’s Old CEO Back, Disney-Style
WSJ News Exclusive Heard on the Street Billionaire activist signals he wants company’s retired CEO Jay Flatley to come back and Grail divested Source link